about_topleft.png

Training the next generation

training_the_next_generation.pngThe Harvard NeuroDiscovery Center Fellowship Program encourages young physicians and scientists to devote their careers to understanding and treating patients with neurodegenerative diseases. We also provide them with the very best training and support.

Dr. Vik Khurana arrived from Australia (where he had recently completed his medical training) to take up a Harvard NeuroDiscovery Center Predoctoral Fellowship.  Like many young physicians, Vik was unsure where to focus his efforts and how to combine his clinical and research interests.  The Harvard NeurDiscovery Center Fellowship provided support for four years during which he developed important research skills and a passion for Alzheimer’s disease and other neurodegenerative diseases.  Working closely with Dr. Mel Feany, an expert on using animals to understand human diseases, Vik was soon engaged in important and ultimately very successful research into the root causes of Alzheimer’s disease and the design of potential new therapies.

Having been awarded his PhD in 2006, Dr. Khurana is now fully devoted to helping Alzheimer’s patients via his clinical and laboratory work.


About the Harvard NeuroDiscovery Center

Established in 2001 by Dr. Joseph Martin (Dean of Harvard Medical School, 1997-2007), the Harvard NeuroDiscovery Center is a pioneering biomedical research group focused on ending suffering from neurodegenerative diseases. By drawing on the intellectual strength and proven capability of the Harvard medical community and colleagues throughout the world, the NeuroDiscovery Center has developed a unique approach to understanding and treating these devastating diseases. 

Our focus:

  • Alzheimer's, Parkinson's, multiple sclerosis, ALS (amyotrophic lateral sclerosis) and other degenerative diseases of the brain.

  • Combining academic creativity with a business-like approach to ensure a focused and efficient effort to advance the search for cures.

  • Accelerating the pace of progress, from "scientific discoveries" to meaningful patient treatments.

  • Real collaboration across the Harvard Medical community, prominent research centers worldwide and the private sector.

  • Applying discoveries about one neurodegenerative disease to better understand the others. 

Whereas our ultimate goal is simple — to improve the lives of the millions who face the physical, emotional, and economic burden of neurodegenerative diseases — these diseases represent a far too complex and urgent problem for any one group to tackle. To date, we have engaged over 600 researchers in a growing portfolio of outcome-directed research programs. For visionary philanthropists and scientists, participation in the Harvard NeuroDiscovery Center's work offers the best hope for progress — please join us!